161 episodes

New Retina Radio is a place to hear stories about retina that are told nowhere else.

New Retina Radio by Eyetube Eyetube

    • Science
    • 4.3 • 16 Ratings

New Retina Radio is a place to hear stories about retina that are told nowhere else.

    New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

    New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

    How do endophthalmitis rates after intravitreal injection differ after using povidone-iodine compared with chlorhexidine? Moderator Sruthi Arepalli, MD, hears from panelists Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH, about a recent peer-reviewed retrospective cohort study on this topic. After the break, the trio discuss how to manage patients who do not tolerate antiseptics, the benefits of visualizing antiseptics on the conjunctiva, and the specific practice patterns that work best in their clinics. 

    • 15 min
    Successful Management of Vitreous Opacities

    Successful Management of Vitreous Opacities

    Performing surgery for symptomatic vitreous opacities (SVO) was once verboten in retina medicine, but the field has seen a sea-change in mindset over the past decade. In this podcast, moderator John Kitchens, MD, is joined by Edwin H. Ryan, MD; Christina Y. Weng, MD, MBA; and Alison Bozung, OD, to explore why surgery for SVO has become more palatable and how this evolution in mindset is impacting patients' quality of life. 

    • 25 min
    New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery

    New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery

    Do the status of the fovea and/or the timing of surgery affect visual outcomes following RRD repair? Join New Retina Radio Journal Club host Lediana Goduni, MD, as she and panelists Matt Starr, MD, and Joshua Uhr, MD, dissect the findings of a recent paper exploring this question. After the break, the trio discusses tactics for overcoming challenges to real-world conditions when patients present at times when immediate surgery is not an option. 

    • 20 min
    Treating Geographic Atrophy (GA) In Your Practice

    Treating Geographic Atrophy (GA) In Your Practice

    Sponsored by Apellis Pharmaceuticals. Scott Walter, MD, and Esther Kim, MD, join John W. Kitchens, MD, to discuss how they treat GA in their practices. Listen to gain expert insights as Drs. Kim, Walter, and Kitchens each share their experiences with this treatment. They also share best practices for dosing based on trial data.

    • 17 min
    Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy

    Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy

    Sponsored by Apellis Pharmaceuticals. John W. Kitchens, MD, invites Scott Walter, MD, and Esther Kim, MD, to discuss best practices for identifying appropriate patients with GA for treatment. Gain perspectives on patient selection, patient education, and safety considerations.

    • 20 min
    The State of Biosimilars: How We Got Here and What It Means for Practice

    The State of Biosimilars: How We Got Here and What It Means for Practice

    Two biosimilars are approved for use in retina by the US FDA—and more will be approved in the coming years. What exactly are biosimilars? What benefit might they provide? And how confident are retina specialist that biosimilars will deliver safe, high-quality care? 

    Moderator John Kitchens, MD, sits down with retina specialists Carl Awh, MD, and Firas Rahhal, MD, to answer these questions, and to ask whether the economic realities of biosimilars make them a good choice for modern retina practices. 

    This podcast is editorially independent, supported with advertising by Cimerli. 

    • 25 min

Customer Reviews

4.3 out of 5
16 Ratings

16 Ratings

Champ0506 ,

Depressing

I have yet to hear information regarding retinitis pigmentosa! 😩 have advanced arRP. Need stem cell and crisper. Rare gene (RP59) small enough for gene therapy but I’m too advanced for gene therapy. Traveled all over the world, including Japan. Will do ANYTHING to be in a clinical trial. Please help. Only 37.

Landon Hawkins ,

June 22, 2020 podcast!!!

The one about $LCTX is very interesting!!

Steve H MD ,

NRR rocks!

Awesome podcast! Very relevant for retina surgeons. John Kitchens is a master interviewer and moderator.

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Radiolab
WNYC Studios
Ologies with Alie Ward
Alie Ward
StarTalk Radio
Neil deGrasse Tyson
Reinvent Yourself with Dr. Tara
Dr. Tara Swart Bieber

You Might Also Like

RETINA Journal Podcasts
Jonathan L. Prenner, MD
Straight From The Cutter's Mouth: A Retina Podcast
Jayanth Sridhar
The Retina Channel Podcast
Keyvan Koushan, MD, FRCSC
Retina Synthesis
Retina Synthesis
Talking Euretina
Whipsmart Media
Experts InSight
American Academy of Ophthalmology